Primaquine five days vs 14 days: P. vivax parasitaemia detected > 30 days after starting primaquine
Primaquine five days probably leads to higher P. vivax parasitaemia detected > 30 days after starting primaquine compared with 14 days (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Primaquine five days vs 14 days P. vivax parasitaemia detected > 30 days after starting primaquine · People with P. vivax malaria1 Primaquine five days probably leads to higher P. vivax parasitaemia detected > 30 days after starting primaquine compared with 14 days (moderate certainty). Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine (2013) · Cochrane Headline outcomes only | RR 10.05 [2.82, 35.86] | 2 studies · 186 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine 2013 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.